Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshihiro Mezaki is active.

Publication


Featured researches published by Yoshihiro Mezaki.


Biopolymers | 2001

Effects of amino acids and chirality for molecular folding of desoxazoline‐ascidiacyclamide derivatives: X‐ray crystal structures of four cyclic octapeptides including unusual amino acids, cyclo(–Ile–aThr–D‐Val–Thz–)2, cyclo(–Ala–aThr–D‐Val–Thz–Ile–aThr–D‐Val–Thz–), cyclo(–Val–aThr–D‐Val–Thz–Ile–aThr–D‐Val–Thz–), and cyclo(–Ile–aThr–Val–Thz–Ile–aThr–D‐Val–Thz–)

Akiko Asano; Mitsunobu Doi; Kiyomi Kobayashi; Masao Arimoto; Toshimasa Ishida; Yoshio Katsuya; Yoshihiro Mezaki; Hiroshi Hasegawa; Masamichi Nakai; Masahiro Sasaki; Taizo Taniguchi; Akira Terashima

Desoxazoline derivative of ascidiacyclamide (1), cyclo(-L-Ile-L-allo-threonine-D-Val-thiazole-)(2), was modified to disturb the C(2)-symmetry. An Ile(1) residue of 1 was replaced for Ala (2) or Val (3), and the D-Val(3) residue was replaced for Val (4). The crystal structures of 1-4 were analyzed by x-ray diffraction methods. The molecules of all compounds were folded and this type of structure was not observed in x-ray structures of ascidiacyclamide derivatives so far except for patellamide D. The folding patterns of 1-4 were similar to each other and resembled that of patellamide. The asymmetric modifications at position 1 caused the conformational changes at local area, and these were related with the peptide-peptide and peptide-solvent interactions. Despite the diverse backbone conformation by the epimeric modification at position 3, the entire molecule of 4 was folded. These results mean that (1) the desoxazoline-ascidiacyclamides favored the folded structures and (2) the modifications of the side chain size at position 1 and the chirality at position 3 brought the local conformational changes to derivatives, suggesting that (3) the lack of the oxazoline block leads to conformational flexibility of 1-4, which accepts the conformational change with no drastic change on the entire structure.


Biochimica et Biophysica Acta | 2000

Crystallization and preliminary X-ray crystallographic analysis of alginate lyase A1-II from Sphingomonas species A1.

Hye-Jin Yoon; Wataru Hashimoto; Yoshio Katsuya; Yoshihiro Mezaki; Kousaku Murata; Bunzo Mikami

Alginate lyase A1-II of Sphingomonas species A1 was purified and crystallized using the hanging drop vapor-diffusion method in 0.1 M Tris-HCl buffer containing 43% saturated ammonium sulfate, 8% polyethylene glycol 4000 and 0.2 M Li(2)SO(4) at pH 8.5 and 20 degrees C. The crystals are tetragonal and belong to the space group P4(3)2(1)2 or P4(1)2(1)2 with unit cell dimensions of a=b=144.07 and c=296.38 A. The diffraction data up to 2.8 A were collected by a synchrotron radiation source at SPring-8 in Japan.


Biopolymers | 2000

Amphipathic structure of theonellapeptolide-Id, a hydrophobic tridecapeptide lactone from the Okinawa marine sponge Theonella swinhoei.

Mitsunobu Doi; Toshimasa Ishida; Motomasa Kobayashi; Yoshio Katsuya; Yoshihiro Mezaki; Masahiro Sasaki; Akira Terashima; Taizo Taniguchi; Chikako Tanaka

Theonellapeptolide-Id (TNLP), a cyclic tridecapeptide lactone, was crystallized from dimethylformamide-water solution. In the asymmetric unit, two peptide molecules were combined with solvent molecules, and the total molecular weight was over 3000 Dalton. The crystal structure including solvent molecules was finally determined at 0.80 A resolution using synchrotron radiation. The conformations of two independent molecules were similar to each other and were also similar to the previously reported structure (Doi, Ishida, Kobayashi, Deschamps and Flippen-Anderson, 1999, Acta Crystallogr Sect C, 55, 796-798). About 13 hydrated water molecules were found at disordered 19 sites; they were located at a certain region to avoid contact with aliphatic side-chains of peptolide in the crystal. The spatial disposition of the solvent molecules and peptides subsequently caused the formation of the amphipathic layer.


Acta Crystallographica Section D-biological Crystallography | 2001

Caged and clustered structures of endothelin inhibitor BQ123, cyclo(-d-Trp-d-Asp−-Pro-d-Val-Leu-)\cdotNa+, forming five and six coordination bonds between sodium ions and peptides

Mitsunobu Doi; Akiko Asano; Toshimasa Ishida; Yoshio Katsuya; Yoshihiro Mezaki; Masahiro Sasaki; Akira Terashima; Taizo Taniguchi; Hiroshi Hasegawa; Masaaki Shiono

BQ123 is a cyclic pentapeptide and a potent endothelin-1 inhibitor. The crystal structure of the BQ123 sodium salt was determined as the first example of an endothelin inhibitor. Four independent molecules and many solvent molecules were found in the asymmetric unit; the total weight was about 3000 Da. The precise structure including the solvent molecules was determined using high-resolution data collected on a synchrotron source. Sodium ions formed unique structures with five and six coordination bonds and their forms were distinguished into three classes. An ion was sandwiched by two BQ123 molecules. This peptide-sodium (2:1) complex showed a cage-like structure and octahedral coordination was observed. Sodium ions also formed a cluster composed of hydrated water molecules and peptides. Two sodium ions were contained in this cluster, making five coordination bonds. Despite having the same coordination numbers, these ions were distinguishable by differences in the polyhedra. One was trigonal bipyramidal (having six planes) and the other was square pyramidal (having five planes). Both shapes were very similar to each other, although the synchrotron data clearly revealed slight geometrical differences.


Chemical Communications | 2000

Unique sodium-caged structure of a potent endothelin-1 inhibitor: crystal structure of BQ123 sodium salt, cyclo(-D-Trp-D-Asp−-Pro-D-Val-Leu-)·Na+

Mitsunobu Doi; Toshimasa Ishida; Yoshio Katsuya; Yoshihiro Mezaki; Masahiro Sasaki; Akira Terashima; Taizo Taniguchi; Hiroshi Hasegawa; Masaaki Shiono

The crystal structure of cyclo(D-Trp-D-Asp−-Pro-D-Val-Leu-)·Na+, a potent endothelin-1 antagonist, showed four conformational isomers and two Na+-caged structures in pairs.


Journal of Molecular Biology | 1998

Three-dimensional structure of Pseudomonas isoamylase at 2.2 A resolution.

Yoshio Katsuya; Yoshihiro Mezaki; Michio Kubota; Yoshiki Matsuura


Journal of Molecular Biology | 1998

Regular articleThree-dimensional structure of Pseudomonas isoamylase at 2.2 Å resolution1

Yoshio Katsuya; Yoshihiro Mezaki; Michio Kubota; Yoshiki Matsuura


Journal of Molecular Biology | 2006

Crystal structure of pullulanase: evidence for parallel binding of oligosaccharides in the active site

Bunzo Mikami; Hiroyuki Iwamoto; Dominggus Malle; Hye-Jin Yoon; Elif Demirkan-Sarikaya; Yoshihiro Mezaki; Yoshio Katsuya


Journal of Peptide Research | 2008

Effect of asymmetric modification on the conformation of ascidiacyclamide analogs

Akiko Asano; Katsuhiko Minoura; Takeshi Yamada; Atsushi Numata; Toshimasa Ishida; Yoshio Katsuya; Yoshihiro Mezaki; Masahiro Sasaki; Taizo Taniguchi; Masamichi Nakai; Hiroshi Hasegawa; Akira Terashima; Mitsunobu Doi


Bioscience, Biotechnology, and Biochemistry | 2001

Crystallization and Structural Analysis of Intact Maltotetraose-forming Exo-amylase from Pseudomonas stutzeri

Yoshihiro Mezaki; Yoshio Katsuya; Michio Kubota; Yoshiki Matsuura

Collaboration


Dive into the Yoshihiro Mezaki's collaboration.

Top Co-Authors

Avatar

Yoshio Katsuya

Osaka University of Pharmaceutical Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mitsunobu Doi

Osaka University of Pharmaceutical Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Toshimasa Ishida

Osaka University of Pharmaceutical Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Akiko Asano

Osaka University of Pharmaceutical Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge